Related Experiment Videos
Cromolyn and nedocromil therapy of asthmatic children
1University of Washington, School of Medicine, Seattle.
Insights
Cromolyn treatment for children with asthma significantly reduces asthma symptoms and bronchial hyperreactivity. It also mitigates beta-receptor desensitization from beta-adrenergic drugs, offering a safer, effective asthma management option.
Area of Science:
- Pediatric Pulmonology
- Allergy and Immunology
- Pharmacology
Background:
- Asthma in children presents significant health challenges.
- Current asthma treatments have limitations and potential side effects.
- Cromolyn sodium is an established antiasthmatic medication.
Purpose of the Study:
- To evaluate the efficacy of cromolyn in pediatric asthma patients.
- To assess the impact of cromolyn on bronchial hyperreactivity.
- To investigate cromolyn's role in mitigating side effects of beta-adrenergic agonists.
Main Methods:
- Analysis of controlled studies involving cromolyn treatment in asthmatic children.
- Assessment of asthma symptom frequency and severity.
- Measurement of bronchial hyperreactivity.
- Evaluation of beta-receptor sensitivity during concomitant medication use.
Main Results:
- Cromolyn treatment for over two months led to decreased asthma symptoms.
- Significant reduction in bronchial hyperreactivity was observed.
- Concomitant cromolyn use with beta-adrenergic drugs abated reduced beta-receptor sensitivity.
Conclusions:
- Cromolyn offers significant benefits for managing pediatric asthma.
- Its safety profile is a key advantage.
- Further research into related antiasthmatic medications like nedocromil is warranted.
Abstract:
Controlled studies of cromolyn treatment of asthmatic children have revealed benefits beyond the incredible safety of the drug. It is now recognized that the patient with asthma will have decreased asthma and less bronchial hyperreactivity when treated for more than two months with cromolyn. Also, the reduced sensitivity of beta-receptors with chronic use of beta adrenergic drugs is abated with concomitant cromolyn use. It is hoped that the studies with nedocromil will reveal additional benefits with this class of antiasthmatic medication.